Arix Bioscience
VC
INVESTOR TYPE
Active
STATUS
7
PROFESSIONALS
26
INVESTMENTS
18
PORTFOLIO
4
EXITS
Description
Arix Bioscience is a venture capital firm founded in 2015 and is based in London, United Kingdom. The firm sources, finances and develops both start-up and later-stage companies across healthcare and life science sectors supporting medical innovation globally.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2015
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 20 Berkeley Square
- London W1J 6EQ
- England, United Kingdom
+44 020 0000 0000
Arix Bioscience Investments & Acquisitions (26)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Amplyx | 09-Jan-2020 | Later Stage VC | 00000 | Pharmaceuticals | Generating Revenue | 000000 00000000 00.0 |
| 00000 000000000000 | 30-Sep-2019 | 00000 00000 | 0000 | Drug Delivery | Startup | 00000000 00000 00.0 |
| 0000 000 | 30-Apr-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - General | 00000000 00000 00.0 |
| 0000 00000000000 | 02-Apr-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | 0000 0000 |
| 00000 | 18-Mar-2019 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 2 | 0000 0000 |
| 0000000 0000000000 | 08-Feb-2019 | 000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | 0000 0000 |
| 0000 00000000000 | 13-Dec-2018 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 1 | 0000 0000 |
| 0000000 0000000000 | 11-Nov-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | 0000 0000 |
| Artios | 09-Aug-2018 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue | 00000000 00000 00.0 |
| BioMotiv | 23-Jul-2018 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Arix Bioscience’s full profile, request a free trial.
Arix Bioscience Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| LogicBio Therapeutics | 19-Oct-2018 | IPO | 0000 | Completed |
|
| 000000 00000000000 | 25-May-2018 | 000 | 0000 | Completed |
|
| Verona Pharma | 26-Apr-2017 | Public Investment 2nd Offering | 0000 | Completed |
|
| Autolus | Secondary Transaction - Open Market | Completed |
|
Arix Bioscience Team (14)
7 Former Team Members
You’re viewing 5 of 14 team members. Get the full list »Arix Bioscience Co-Investors (75)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| OrbiMed | 5 | 0 | |
| Lundbeckfond Ventures | 0 | 0 | |
| Sofinnova Investments | 0 | 0 | |
| Bay City Capital | 0 | 0 | |
| Pappas Capital | 0 | 0 |